​
​

Humanigen Ownership | Who Owns Humanigen?

OverviewForecastChart

Humanigen Ownership Summary

Humanigen is owned by 0.01% institutional investors, and 99.99% retail investors. Guggenheim Active Allocation Fund is the top mutual fund, with 0.00% of its assets in Humanigen shares.

HGEN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockHumanigen0.01%-99.99%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Guggenheim Active Allocation Fund284.000.00%284.00
BMO MSCI Genomic Innovation ETF80.000.00%80.00

Recent Insider Transactions

DateNameRoleActivityValue
Oct 18, 2023Chappell Dale Chief Scientific OfficerSell$3.04K
Oct 18, 2023Chappell Dale Chief Scientific OfficerSell$376.78
Oct 18, 2023Chappell Dale Chief Scientific OfficerSell$834.76
May 18, 2022Cheval Holdings, Ltd. Buy$121.54K
Mar 11, 2022Cheval Holdings, Ltd. Buy$2.10M

Insider Transactions Trends

DateBuySell
2023 Q4-3
2022 Q3--
2022 Q21-
2022 Q16-
2021 Q4--

HGEN Ownership FAQ

Who Owns Humanigen?

Humanigen shareholders are primarily institutional investors at 0.01%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Humanigen's industry, Biotech Stocks , is 45.35%, which Humanigen falls below.

Does Blackrock own Humanigen?

BlackRock is not among the top 10 institutional shareholders of Humanigen.

Who is the top mutual fund holder of Humanigen shares?

Guggenheim Active Allocation Fund is the top mutual fund holder of Humanigen shares, with 0.00% of its total shares outstanding invested in 284 Humanigen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools